Pharmaceutical Institute Industrial pharmacy 201-”A” group Sharofiddinov Jasurbek

Pharmaceutical Institute

Industrial pharmacy

201-”A” group

Sharofiddinov Jasurbek

Barbiturates

Barbiturates

• All derivatives of Barbituric acid
• Depressants of the central nervous system (CNS) that impair or reduce the activity of the brain by acting as a Gamma Amino Butyric Acid (GABA) potentiators
• Categorized as hypnotics and also called “downers”
• Produce alcohol like symptoms such as impaired motor control (ataxia), dizziness, and slower breathing and heart rate

History

• Barbituric acid was first created in 1864 by a German scientist named Adolf von Baeyer. It was a combination of urea from animals and malonic acid from apples.
• Its first derivative utilized as medicine was used to put dogs to sleep but was soon produced by Bayer as a sleep aid in 1903 called Veronal
• Phenobarbital was soon discovered and marketed as well as many other barbituric acid derivatives
• Prescribed as sedatives, anesthetics, anxiolytics, and anti-convulsants
• Also popular and abused in pop culture because of their alcohol like effects

Interesting facts

• Caused the death of many celebrities such as Jimi Hendrix and Marilyn Monroe
• Used by the Nazis during WWII for euthanasia

Types

Barbituric Acid

Amobarbital Phenobarbital Pentobarbital

Synthesis

Malonic Acid Urea Barbituric Acid

Barbituric acid is synthesized by a condensation reaction that results in the release of H2O (dehydration) and the heterocyclic pyrimidine

Further substitution of side chains on the ring produce the pharmacologically active barbiturates

Mechanism of Action

Barbiturates potentiate the effect of GABA at the GABA-A receptor. The GABA-A receptor is a ligand gated ion channel membrane receptor that allows for the flow of Cl through the membrane in neurons. GABA is the principle neurotransmitter for this receptor which upon binding causes the channel to open and creates a negative change in the transmembrane potential. This makes it an Inhibitory neurotransmitter

GABA binding site

Barbiturate binding site

GABA

Mechanism of Action

Barbiturates potentiate the effect of GABA by binding to the GABA-A receptor at a nearby site and increasing the chloride flow through the channel. Barbiturates also block the AMPA receptor which is sensitive to glutamate, the excitatory neurotransmitter. Glutamate performs the opposite effect from GABA restricting ion flow and increasing the transmembrane action potential of the neuron. By blocking this action Barbiturates serve to increase the duration of the receptor response to GABA and extend the depressed condition of the cell.

Uses

Barbiturates have been use in the past to treat a variety of symptoms from insomnia and dementia to neonatal jaundice.

They have largely been replaced with drugs such as benzodiazepine due to their propensity for addiction and reduced effect over extended use.

Still widely used to treat most seizures including neonatal seizures.

Used when benzo class drugs fail or in underdeveloped countries.

Cannot be used for treatment of absence seizures

Future Research

Research continues to develop for Barbiturates as anti-convulsants. More particularly research is being performed to test the prophylactic value of barbiturates in situations such as pre and perinatal asphyxia and epilepsy.